Loading
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (12 ops.)
Latest filing published 29 Dec 2025 for Fennec Pharmaceuticals INC., €6.4M.
Filing timeline
BuySaleSouthpoint Capital Advisors LP
Insider track record
Disclosed buys
5
Disclosed sells
12
Signal history
Closed purchases
Market purchases
5
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -7.9%Entry US$6.70 · Close at T+365 US$6.17
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Southpoint Capital Advisors LP: trading record in brief
This profile gathers the share dealings of Southpoint Capital Advisors LP across 5 companies, led by Fennec Pharmaceuticals Inc., IXI Mobile, Inc. and Lev Pharmaceuticals Inc. Over a trading history stretching from 16 March 2007 to 24 December 2025, the count stands at 18 filings.
Market trades split into 5 purchases (€1.6M) and 12 sales (€10.3M). No amount is published for 5 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings no purchases and 7 sales.
In size, the median ticket on the buying side is €459k.
The record was last updated on 29 December 2025 with an open-market sale (€6.4M) in Fennec Pharmaceuticals Inc. The most recent open-market purchase was published on 6 May 2020, 2,363 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Southpoint Capital Advisors LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
1,000,000 shares@ US$7.5081.2% of flowCommon StockSEC:0001012975-25-000985:0
19,341 shares@ US$8.79211.9% of flowCommon StockSEC:0001012975-25-000806:0
85,918 shares@ US$8.78974.1% of flowCommon StockSEC:0001012975-25-000793:1
160,100 shares@ US$7.997714.1% of flowCommon StockSEC:0001012975-25-000793:0
19,605 shares@ US$9.47321.0% of flowCommon StockSEC:0001012975-25-000621:1
20,609 shares@ US$9.34611.0% of flowCommon StockSEC:0001012975-25-000621:2
26,900 shares@ US$9.58712.8% of flowCommon StockSEC:0001012975-25-000621:0
80,000 shares@ US$6.253.1% of flowCommon StockSEC:0001012975-20-000407:0
Canonical exit: 2 Aug 2020 (T+90)
41,504,000 sharesCommon StockSEC:0001140361-10-025044:0
200,000,000 sharesCommon StockSEC:0001140361-10-019977:0
Canonical exit: 29 Jul 2010 (T+90)
00Common StockSEC:0001209191-10-011440:0
Canonical exit: 23 May 2010 (T+90)
50,200 shares@ US$2.03Common StockSEC:0001209191-09-033356:0
5,400,000 sharesCommon StockSEC:0001209191-09-003633:0
304,354 shares0Series A Preferred StockSEC:0001209191-09-003633:1
304,354 sharesSeries A Preferred StockSEC:0001209191-09-003633:2
6,363,050 shares@ US$0.2528Common StockSEC:0001209191-08-051381:0
Canonical exit: 25 Nov 2008 (T+90)
1,000,000 shares@ US$2.10Common StockSEC:0001209191-07-068198:0
46,500 shares@ US$1.80Common StockSEC:0001209191-07-021698:0
Canonical exit: 14 Jun 2007 (T+90)
18 of 18 declarations
